• linkedin
  • Increase Font
  • Sharebar

    Medicare Part D: New MTM model emphasizes medication adherence

    In September 2015, the Centers for Medicare and Medicaid Services (CMS) expanded its Medicare Part D program to include medication adherence for beneficiaries of its Medicare Part D plans.

    Ned MilenkovichNed MilenkovichAlthough  “medication therapy management” (MTM) is a cognitive intervention of longstanding in pharmacy practice, CMS will now offer payers enticements to increase patient adherence to their medications under the existing MTM model. The Part D effort is specifically focused on stand-alone Part D plans.

    See also: HHS releases 340B Proposed Guidance

    Substantial improvement

    The new Part D MTM model will address whether providing Part D sponsors with additional payment incentives and regulatory flexibilities will sharpen the MTM program, leading to improved therapeutic outcomes while reducing net Medicare expenditures. Stand-alone basic Part D plans can benefit through implemention of innovative strategies to optimize medication use, improve coordination of care, and strengthen system linkages.

    See also: Washington state requires pharmacies to stock Plan B

    Tailored MTM services will be available for participating Part D plans. Factors such as the enrollee’s level of medication-related risk and current barriers to improvement will be used to determine the appropriate services to provide.

    This approach is a substantial improvement over the current model, which provides uniform service offerings to all Part D enrollees who meet the program’s criteria. The criteria, which are based on numbers of medications, chronic conditions, and expected annual prescription drug costs, do not include a variable to account for the enrollee’s specific needs or risk factors.

    The new MTM model comes as stand-alone Part D plan premiums are projected to increase, while the number of plans will decrease.

    Big changes

    Avalere Health, a healthcare consulting firm based in Washington D.C., has released the following figures:

    Ten of the most popular Part D plans, representing more than 80% of Part D plan enrollment, will have an average premium increase of 8% in 2016. This will increase many beneficiaries’ premiums to more than $40 a month, a first since the program’s inception in 2006. The number of plans is dropping 13.5%, from 1,001 currently to 886 next year.

    “Medicare beneficiaries should carefully review their prescription drug plan options in 2016 to make sure they choose a plan that is right for them,” Colin Shannon, senior manager at Avalere Health, said in a statement. “With many plans taking large premium increases in 2016, those beneficiaries who choose not to change plans will likely pay more in premiums than if they look for lower-cost options.”

    Ned Milenkovich, PharmD, JD
    This article is not intended as legal advice and should not be used as such. When legal questions arise, pharmacists should consult with ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available